Year: 2010
-
Will Medicare Cover Provenge? A Dendreon “Hockey Stick” Event Approaches
While winter is approaching and the hockey season has already begun for sports fans, another kind of hockey related event is approaching
-
Beyond the Tipping Point: Medicare Will Control the Rising Cost of Cancer Drugs
The question is no longer whether or not Medicare will do it but when and how. The initiation of a National Coverage Decision
-
Does Folotyn® work in NSCLC? Allos Therapeutics Reports Phase 2 Results
On Wednesday the 28th Allos announced the results of their randomized phase 2 study comparing Folotyn
-
Buying Opportunities? Dendreon; Antisoma
On July 1st CMS announced that Dendreon’s Provenge® will undergo a National Coverage Determination (NCD).
-
Catch a rising star.
This past ASCO in Chicago was something like the 18th or 19th one that I have attended, and it has grown from a few thousand physicians to